Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT00115518
Eligibility Criteria:
Inclusion Criteria:
* Histologically verified NSCLC
* Not eligible for Radiochemotherapy or patient refuses chemotherapy
* FeV1 \>1.5 L or min. 50%
* KPI \>= 70%
* Life expectancy \> 6 months
* Weight loss less than 10% of body weight in 12 months
* Compliance
* Adequate blood counts (LC \> 3000 x 10\^3/ml, Tc \>100000 x 10\^3/ml, Hb \> 10 g/dl)
* Effective contraception
Amendment 1/07: FeV1 \>1.2 L or min 40%
Exclusion Criteria:
* Active infection
* Reduced liver function
* Vena cava superior syndrome
* Malignant pleural effusion
* Pregnancy or breast feeding
* Additional serious systemic disease
* Secondary malignancy (except carcinoma in situ of the cervix, basalioma of the skin, secondary cancer in remission for \> 5 years)
* Known allergies against proteins
* History of former antibody therapy
* Allergy against i.v. contrast agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00115518
Study Brief:
Protocol Section:
NCT00115518